Sign in

CIK 0001810560 · Non-accelerated filer<br>Smaller reporting company

REVELATION BIOSCIENCES, INC.

Sign in to watch
Ticker
REVB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
843898466
Phone
650-800-3717
Business address
4660 LAJOLLA VILLAGE DRIVE, SUITE 100, SAN DIEGO, CA, 92122
Former names
Petra Acquisition Inc.

Securities

  • REVB Common Stock Nasdaq
  • REVBW Warrant Nasdaq
  1. 4 Derivatives Options or other derivatives
  2. 5 Insider Annual Insider Trading Report
  3. 4 Open-market buy Director bought 20,000 shares at $1.60 ($32,000)
  4. 4 Open-market buy Director bought 31,000 shares at an average $2.55 ($79,139)
  5. 4/A Open-market buy Director bought 52,000 shares at an average $2.56 ($132,936)
  6. 4 Open-market buy Director bought 50,000 shares at an average $2.56 ($128,036)
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 4 Other disposition 10% owner disposed of 731,950 shares (other)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale 10% owner sold 654,546 shares at $10.08 ($6,597,824)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Other disposition Chief Executive Officer disposed of 192,962 shares (other)
  18. 4 Other disposition Chief Executive Officer disposed of 192,962 shares (other)
  19. 4 Open-market sale 10% owner sold 5,000 shares at $10.00 ($50,000)
  20. 4 Derivatives Options or other derivatives

Page 3 of 4 · 70 filings